"Live Webinar" How Great Capital Compounding Stocks Power Your Portfolio:
US SaaS, Hidden AI Winners, Hard Assets & Dividend Aristocrats

In 2026, KeyStone welcomed another 10x stock to our growing list of portfolio changing 10x BUY recommendation and we are on the verge of adding another in 2026. The first company, Firan Technology Group (FTG: TSX) has gained another 172% over the past year and is now up 1,383% since our BUY at $1.35.

Argan (AGX:NYSE) – On the verge of 10x: Just 18 months ago, our clients received this BUY report on Argan a highly profitable, cash stock to play the boom in AI Data Centers. The stock has jumped 836% from the $49 range to over $466. Goldman finally just recommended Argan as a BUY – let KeyStone find you unknown, profitable stocks before the big boys!

And it does not stop with FTG and AGX – if you attended our April 2025 Live Webinar (one year ago!) you were introduced to KeyStone Top BUY Groupe Dynamite (GRGD: TSX) at $10.55. The stock has jumped 8x to over $80  and is one of the best (top 2) performing revenue producing stocks on the entire Toronto Stock Exchange over that period.

The 514% gain on Groupe Dynamite Inc. (GRGD:TSX) could have already paid for your subscription well over 20x in less than three months.

• $2,000 invested in Groupe Dynamite is worth $15,418 today.
• $100,000 is worth $770,900 today.

Do not miss out on our Top 2026 BUYs.

KeyStone’s top analysts Ryan Irvine, Brennan Habetler, Brett Rodway, & Rahil Gillani detail 6 plus profitable Canadian & U.S. Growth & Dividend Growth Stock Buy Recommendations.

Join the thousands of Canadians who have already benefited from KeyStone’s no-nonsense stock portfolio-building seminars. Purchase the On-Demand Webinar we will also give you 6 top growth & dividend growth stocks you can buy today including:

#1: Undervalued Infrastructure Stock – record backlog trading at 5x our 2026 EPS estimate with strong growth. – Benefitting from surge in hydroelectric demand and potential nuclear demand increase.

#2: US Fintech Bank – Unknown small-cap, 12x earnings, 3-5 plus year EPS growth path in highly profitable US market; 3 to 5x potential..

#3: Growth-Oriented Unknown US Insurer – trades near book value and at a significant discount to peers.

#4: Little-Known Capital Compounding Specialty Pharma: strong cash generation to acquire without dilution, strong organic growth 12x EPS, recession resistant.

#5: Undervalued Gold Stock (Canada)  – Cash-rich, 5x earnings, growing dividend, expansion plans suggest 3–4x upside.

#6: Two Cash Rich Small-Cap stocks with strong long-term growth – one with 60+ percent of its market cap in cash at 4-5x earnings – highly profitable with growth expected this year after a pause in 2025 – additional growth-by-acquisition from cash.

 “Investing in just 2 or 3 truly great stocks in your lifetime can be game changing for your portfolio.”

This past year Warren Buffett, perhaps the greatest investor of all time, stated that “In his 58 years of Berkshire management (his) satisfactory results have been the product of about a dozen truly good decisions – that would be about one every five years.”

Let that sink in. Only 12 great investments (stocks) in his almost hundred years on earth, have made him one of the richest humans on the planet.

Truly great stocks create truly great wealth. It’s that simple. Unfortunately, if you construct your portfolio with the traditional Big Bank approach, buying 5-20 mutual funds and ETFs which each own 100+ stocks, you cannot take advantage of these great stocks. A portfolio built in this manner owns 500 to 1000s of stocks and will mirror the market (because it is the market) but underperform due to the high fees. There is a better way. 

Focused Diversification – the better way to build a portfolio.

Let KeyStone help you build a simple 20-25 stock portfolio designed to save on fees and position you to benefit from great capital compounding stocks.

Use our research to fill these four core areas in your portfolio with 20-25 stocks over a 24-month period.